Vaginal versus oral indomethacin in a rabbit model for non-infection-mediated preterm birth: an alternate tocolytic approach.

Am J Obstet Gynecol

Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Miller Children's Hospital, Women's Pavilion, Long Beach, CA, USA.

Published: October 2006

Objective: We examined the hypotheses that vaginal indomethacin is more effective for prolonging gestation, and mediates its tocolytic actions via changes in cervical matrix metalloproteinase (MMP) activity, compared to oral.

Study Design: Pregnant rabbits induced with mifepristone received oral or vaginal indomethacin; or oral or vaginal vehicle once daily for 2 days. Premature delivery, fetal ductus arteriosus, and cervical MMP activity were assessed.

Results: Vaginal indomethacin delayed delivery >72 hours in 100% of the rabbits, extending gestation to 28.2 +/- 0.5 (P < .01) versus 26.4 +/- 0.3, 25.8 +/- 0.5, and 26.5 +/- 0.3 days, for vaginal placebo, oral indomethacin, and oral vehicle, respectively. Fetal ductus arteriosus was patent in all groups. Vaginal indomethacin decreased MMP-1, -8, and -9 activities and increased TIMP-1 levels in the cervix.

Conclusion: Vaginal indomethacin is more effective than oral for prolonging gestation in the rabbit. Its tocolytic effects may be mediated, in part, by alterations in cervical MMP activity.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ajog.2006.06.037DOI Listing

Publication Analysis

Top Keywords

vaginal indomethacin
20
mmp activity
12
vaginal
8
oral indomethacin
8
indomethacin effective
8
prolonging gestation
8
oral vaginal
8
indomethacin oral
8
fetal ductus
8
ductus arteriosus
8

Similar Publications

Background: Necrotizing fasciitis in neonates is a rare and life-threatening infection involving necrosis of the skin, subcutaneous tissues, deep fascia, and sometimes underlying muscles, with a fulminant course and high mortality rate. Necrotizing fasciitis with gas gangrene related to infection of a peripherally inserted central catheter is very rare.

Case Presentation: The patient was a full-term female neonate born by vaginal delivery.

View Article and Find Full Text PDF

Introduction: Cervical insufficiency accounts for 15% of recurrent pregnancy losses between 16 and 28 weeks of gestation. The aim of the study is to verify the effectiveness of emergency double-level cerclage with vaginal progesterone in cervical insufficiency treatment in terms of the prevention of preterm delivery before 34 weeks of gestation.

Methods And Analysis: This trial is a multicentre, non-blinded, randomised study with 1:1 allocation ratio.

View Article and Find Full Text PDF

Background: Cervical competence is currently conceived as a continuous biological process with progressive degrees of insufficiency, this substituting the traditional vision of cervical competence as being present or absent. The most extreme expression of cervical insufficiency is known as "hourglass membranes". Currently no consensus exists regarding the treatment of pregnancies complicated by the protrusion of amniotic membranes; however, the majority of authors agree on recommending bed rest and performing cervical cerclage, known as "emergent cerclage.

View Article and Find Full Text PDF
Article Synopsis
  • Preterm birth (PTB) is a major cause of complications for newborns, and preventing it is crucial, particularly using cervical cerclage for women with a short cervix who are at high risk.
  • This study aims to evaluate the effectiveness of combining cervical cerclage with treatments like antibiotics, pessaries, or progesterone to help prolong pregnancy in women with a risk history of PTB.
  • Previous reviews have not looked at the combination of treatments with cervical cerclage, highlighting a gap in understanding this intervention's effectiveness in preventing premature deliveries.
View Article and Find Full Text PDF

anti-inflammatory potential of phloretin microemulsion as a new formulation for prospective treatment of vaginitis.

Pharm Dev Technol

October 2020

Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Ain Shams University, Cairo, Egypt.

Phloretin is a promising polyphenolic compound known for its anti-inflammatory properties, but its poor solubility and low bioavailability hinder its clinical applicability. Till current date, its potential in the treatment of vaginitis has not been explored, and only very few papers reported its formulation as nanoparticles to overcome its pharmaceutical challenges. Therefore, in the current study, phloretin was formulated in microemulsion of 11 nm size, and its anti-inflammatory properties were explored using histamine and IL-6 release inhibition assays, protease inhibition assay, and membrane stabilization potential.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!